Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers

<p>Abstract</p> <p>Background</p> <p>A small fraction of Human T cell Leukemia Virus type-1 (HTLV-I) infected subjects develop a severe form of myelopathy. It has been established that patients with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) sho...

Full description

Bibliographic Details
Main Authors: Gollob Kenneth J, Dutra Walderez O, Melo Ailton, Magalhães Elza, de Jesus Amélia, Muniz André, Porto Aurélia, Santos Silvane, Carvalho Edgar M
Format: Article
Language:English
Published: BMC 2004-03-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://www.biomedcentral.com/1471-2334/4/7
id doaj-f4865604ad50445192c7718897fb69a0
record_format Article
spelling doaj-f4865604ad50445192c7718897fb69a02020-11-25T03:07:17ZengBMCBMC Infectious Diseases1471-23342004-03-0141710.1186/1471-2334-4-7Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriersGollob Kenneth JDutra Walderez OMelo AiltonMagalhães Elzade Jesus AméliaMuniz AndréPorto AuréliaSantos SilvaneCarvalho Edgar M<p>Abstract</p> <p>Background</p> <p>A small fraction of Human T cell Leukemia Virus type-1 (HTLV-I) infected subjects develop a severe form of myelopathy. It has been established that patients with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) show an exaggerated immune response when compared with the immunological response observed in HTLV-I asymptomatic carriers. In this study the immunological responses in HAM/TSP patients and in HTLV-I asymptomatic carriers were compared using several immunological assays to identify immunological markers associated with progression from infection to disease.</p> <p>Methods</p> <p>Immunoproliferation assays, cytokine levels of unstimulated cultures, and flow cytometry analysis were used to evaluate the studied groups. Nonparametric tests (Mann-Whitney U test and Wilcoxon matched-pairs signed ranks) were used to compare the difference between the groups.</p> <p>Results</p> <p>Although both groups showed great variability, HAM/TSP patients had higher spontaneous lymphoproliferation as well as higher IFN-γ levels in unstimulated supernatants when compared with asymptomatic carriers. Flow cytometry studies demonstrated a high frequency of inflammatory cytokine (IFN-γ and TNF-α) producing lymphocytes in HAM/TSP as compared to the asymptomatic group. This difference was accounted for mainly by an increase in CD8 cell production of these cytokines. Moreover, the HAM/TSP patients also expressed an increased frequency of CD28-/CD8+ T cells. Since forty percent of the asymptomatic carriers had spontaneous lymphoproliferation and IFN-γ production similar to HAM/TSP patients, IFN-γ levels were measured eight months after the first evaluation in some of these patients to observe if this was a transient or a persistent situation. No significant difference was observed between the means of IFN-γ levels in the first and second evaluation.</p> <p>Conclusions</p> <p>The finding that a large proportion of HTLV-I carriers present similar immunological responses to those observed in HAM/TSP, strongly argues for further studies to evaluate these parameters as markers of HAM/TSP progression.</p> http://www.biomedcentral.com/1471-2334/4/7HTLV-IHAM/TSPHTLV-I carriersImmunological response in HTLV-I infectionMarkers of HAM/TSP progression.
collection DOAJ
language English
format Article
sources DOAJ
author Gollob Kenneth J
Dutra Walderez O
Melo Ailton
Magalhães Elza
de Jesus Amélia
Muniz André
Porto Aurélia
Santos Silvane
Carvalho Edgar M
spellingShingle Gollob Kenneth J
Dutra Walderez O
Melo Ailton
Magalhães Elza
de Jesus Amélia
Muniz André
Porto Aurélia
Santos Silvane
Carvalho Edgar M
Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
BMC Infectious Diseases
HTLV-I
HAM/TSP
HTLV-I carriers
Immunological response in HTLV-I infection
Markers of HAM/TSP progression.
author_facet Gollob Kenneth J
Dutra Walderez O
Melo Ailton
Magalhães Elza
de Jesus Amélia
Muniz André
Porto Aurélia
Santos Silvane
Carvalho Edgar M
author_sort Gollob Kenneth J
title Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
title_short Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
title_full Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
title_fullStr Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
title_full_unstemmed Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers
title_sort exacerbated inflammatory cellular immune response characteristics of ham/tsp is observed in a large proportion of htlv-i asymptomatic carriers
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2004-03-01
description <p>Abstract</p> <p>Background</p> <p>A small fraction of Human T cell Leukemia Virus type-1 (HTLV-I) infected subjects develop a severe form of myelopathy. It has been established that patients with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) show an exaggerated immune response when compared with the immunological response observed in HTLV-I asymptomatic carriers. In this study the immunological responses in HAM/TSP patients and in HTLV-I asymptomatic carriers were compared using several immunological assays to identify immunological markers associated with progression from infection to disease.</p> <p>Methods</p> <p>Immunoproliferation assays, cytokine levels of unstimulated cultures, and flow cytometry analysis were used to evaluate the studied groups. Nonparametric tests (Mann-Whitney U test and Wilcoxon matched-pairs signed ranks) were used to compare the difference between the groups.</p> <p>Results</p> <p>Although both groups showed great variability, HAM/TSP patients had higher spontaneous lymphoproliferation as well as higher IFN-γ levels in unstimulated supernatants when compared with asymptomatic carriers. Flow cytometry studies demonstrated a high frequency of inflammatory cytokine (IFN-γ and TNF-α) producing lymphocytes in HAM/TSP as compared to the asymptomatic group. This difference was accounted for mainly by an increase in CD8 cell production of these cytokines. Moreover, the HAM/TSP patients also expressed an increased frequency of CD28-/CD8+ T cells. Since forty percent of the asymptomatic carriers had spontaneous lymphoproliferation and IFN-γ production similar to HAM/TSP patients, IFN-γ levels were measured eight months after the first evaluation in some of these patients to observe if this was a transient or a persistent situation. No significant difference was observed between the means of IFN-γ levels in the first and second evaluation.</p> <p>Conclusions</p> <p>The finding that a large proportion of HTLV-I carriers present similar immunological responses to those observed in HAM/TSP, strongly argues for further studies to evaluate these parameters as markers of HAM/TSP progression.</p>
topic HTLV-I
HAM/TSP
HTLV-I carriers
Immunological response in HTLV-I infection
Markers of HAM/TSP progression.
url http://www.biomedcentral.com/1471-2334/4/7
work_keys_str_mv AT gollobkennethj exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT dutrawalderezo exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT meloailton exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT magalhaeselza exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT dejesusamelia exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT munizandre exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT portoaurelia exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT santossilvane exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
AT carvalhoedgarm exacerbatedinflammatorycellularimmuneresponsecharacteristicsofhamtspisobservedinalargeproportionofhtlviasymptomaticcarriers
_version_ 1724671374848425984